Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

1,2 The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA ... jobs to the current 100-plus workforce at this location. Eli Lilly and Company (NYSE: LLY) today ...

An "exciting" new study has found that Semaglutide, the active ingredient of Wegovy and Ozempic ... but researchers who looked at how the injections impacted the health of people with diabetes ...

Compounded weight-loss medications such as those promoted in the Hims & Hers commercial aren’t approved by the Food and Drug ...

The first clinical trial of its kind found the weekly jab semaglutide, also known as Ozempic and Wegovy, cuts the amount ... lab setting one week before injections and asked to drink their ...

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really does help curb drinking ...

In addition to Wegovy, incretin mimetics FDA-approved for chronic weight management include Saxenda (liraglutide), also made by Novo Nordisk, and Zepbound (tirzepatide), produced by Fortune 500 ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

When giving gluteal injections, it is safest to use the upper outer quadrant. The choice of site for injection must be based on good clinical judgment, using the best evidence available and ...

After telehealth brand Hims & Hers aired its first Super Bowl commercial Sunday night, competitor Novo Nordisk, which makes competing weight loss drugs Ozempic and Wegovy, responded with its own ...